Cargando…
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
The mammalian target of rapamycin (mTOR) plays a key role in several cellular processes: proliferation, survival, invasion, and angiogenesis, and therefore, controls cell behavior both in health and in disease. Dysregulation of the mTOR signaling is involved in some of the cancer hallmarks, and thus...
Autores principales: | Ciołczyk-Wierzbicka, Dorota, Gil, Dorota, Zarzycka, Marta, Laidler, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965047/ https://www.ncbi.nlm.nih.gov/pubmed/31586300 http://dx.doi.org/10.1007/s13577-019-00270-4 |
Ejemplares similares
-
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2019) -
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2023) -
Correction to: Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2023) -
Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2017) -
The inhibition of invasion of human melanoma cells through N-cadherin knock-down
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2018)